Bausch + Lomb Corporation
- BLCO
- NYSE
- Medical - Instruments & Supplies
- Contact Lenses & Vision Care
- Ophthalmic Pharmaceuticals
- Eye Surgery Devices
$16.59
Today +0.61%Quote Oct 19, 2026, 07:39 PM UTC
−1.67%over the last month
Max drawdown −8.8%From 1-month high −4.9%3 months +3.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Bausch + Lomb
Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical.
Where the money comes from
Q2 2026 revenue $1.39B
- Device Products$524.0M37.6%
- Over the Counter Products$497.0M35.7%
- Pharmaceutical Products$300.0M21.5%
- Branded and Other Generic Products$68.0M4.9%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Employees
13,000
Founded
1853
Market value
$5.93B
Quote Oct 19
Floor
$16.59
0.0% below price
Resistance
$16.70
0.7% above price
Price vs analyst targets
17 analysts
Lowest target
$16.00Highest target
$24.00
$16.00Highest target
$24.00
- Price $16.59
- Average target $20.83
- Analysts' target range
The price is close to the lowest analyst target. Analysts' average target sits about 26% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BLCOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free